tm logo

Monitor this mark

View On USPTO

THE REGENERON PRIZE FOR CREATIVE INNOVATION
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 27 Apr 2024

Last Applicant/ Owned by

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road

Tarrytown

NY

10591

Serial Number

86920153 filed on 25th Feb 2016

Registration Number

5312297 registered on 17th Oct 2017

in the Principal Register

Correspondent Address

Terrence J. McAllister

Terrence J. McAllister Ruggiero McAllister & McMahon LLC

18TH FLOOR

STAMFORD, CT 06901

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

THE REGENERON PRIZE FOR CREATIVE INNOVATION

Providing recognition and incentives by the way of awards featuring prizes to demonstrate excellence in the biomedical field

Classification Information

Class [041]
Education and Entertainment Services

Providing recognition and incentives by the way of awards featuring prizes to demonstrate excellence in the biomedical field

First Use Date in General

27th Jun 2013

First Use Date in Commerce

27th Jun 2013

Mark Details

Serial Number

No 86920153

Mark Type

No Service Mark

Attorney Docket Number

No 554.0974UST1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Apr 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
27th Apr 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
25th Apr 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Oct 2023TEAS SECTION 8 & 15 RECEIVED
17th Oct 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14th Jul 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Jul 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Jul 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17th Oct 2017REGISTERED-PRINCIPAL REGISTER
12th Sep 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED